Comparison between the effects of spironolactone and eplerenone in the treatment of heart failure

Phase 3

Recruiting

• Conditions: Systolic heart failure.; Left ventricular failure; I50.1

• Registration Number: IRCT20130422013090N4
• Lead Sponsor: Sari University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

New onset symptomatic systolic heart failure with left ventricular systolic ejection fraction less than 40%

Exclusion Criteria

Pregnancy
Previous use of aldosterone antagonists
Severe coronary artery disease with need to revascularization

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eft ventricular ejection fraction. Timepoint: at the beginning of the study and 6 months after starting treatment. Method of measurement: Echocardiography.;Global longitudinal systolic strain. Timepoint: at the beginning of the study and 6 months after starting treatment. Method of measurement: Echocardiography.